A phase 1 study to evaluate NPT189

Next Previous
Trial Profile

A phase 1 study to evaluate NPT189

Planning
Phase of Trial: Phase I

Latest Information Update: 04 Apr 2018

At a glance

  • Drugs NPT-189 (Primary)
  • Indications Amyloidosis
  • Focus Adverse reactions

    • Most Recent Events

    • 04 Apr 2018 New trial record
    • 28 Mar 2018 According to a Proclara media release, the company expects to initiate this Phase 1 clinical study in mid-2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top